Prime Editing Creates Drug-Controllable T Cell Therapies

• October 28, 2026

Nativity and US Residence Duration and Colorectal Cancer Screening Nonadherence

• by Sebastian O. Ekenze, Areesh Mevawalla, Aayan E. Kibria, Kizuki Yuza, Abdulaziz Elemosho, Timothy M. Pawlik

• October 19, 2026

Diagnostic performance and pathologic associations of the UroVysion assay in patients with upper tract lesions and negative urinary cytology: a large-scale real-world study of 1,256 patients

• by Longtao Zheng, Bao Guan, Zheng Wu, Yi Ding, Bei Zhang, Xuesong Li, Yanqing Gong

• October 18, 2026

Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells

The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice

• October 21, 2026

• 3 min